Botanical species · safety record

Brunfelsia grandiflora

The EFSA Compendium of Botanicals holds 20 constituent measurements and 1 adverse-effect record for Brunfelsia grandiflora. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Brunfelsia grandiflora D.Don.

20Constituent measurements
1Safety records
7Cited sources
0Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Scopoletin7
  • Brunfelsamidine2
  • Methyl salicylate2
  • 2-ethylfuran1
  • Benzaldehyde1
  • Cirensenoside p1
  • Ethyl salicylate1
  • Hex-3-enyl salicylate1
  • Isobutyl salicylate1
  • P-tolualdehyde1

Plant parts

  • Aerial part of plants9
  • Roots and other underground parts7
  • Leaves2
  • Bark1
  • Seed1
  • Trunk1

Preparations

  • Solvent extraction21

Effect types

  • Neurotoxicity1

Target tissues

  • Neurologic1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
BrunfelsamidineRoots and other underground partsSolvent extractionResolve DOI
BrunfelsamidineRoots and other underground partsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Cirensenoside pLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Methyl salicylateRoots and other underground partsSolvent extractionResolve DOI
PyrrolidoneRoots and other underground partsSolvent extractionResolve DOI
ScopoletinBarkSolvent extractionResolve DOI
ScopoletinRoots and other underground partsSolvent extractionResolve DOI
ScopoletinRoots and other underground partsSolvent extractionMass Spectroscopy and hyphenated methods without chromatographyResolve DOI
ScopoletinTrunkSolvent extractionResolve DOI
ScopoletinLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
ScopoletinRoots and other underground partsSolvent extractionResolve DOI
2-ethylfuranAerial part of plantsSolvent extraction0.05 PercentGC-FIDNo resolvable identifier
BenzaldehydeAerial part of plantsSolvent extraction0.05 PercentGC-FIDNo resolvable identifier
Ethyl salicylateAerial part of plantsSolvent extraction0.09 PercentGC-FIDNo resolvable identifier
Hex-3-enyl salicylateAerial part of plantsSolvent extraction0.26 PercentGC-FIDNo resolvable identifier
Isobutyl salicylateAerial part of plantsSolvent extraction0.07 PercentGC-FIDNo resolvable identifier
Methyl salicylateAerial part of plantsSolvent extraction61.49 PercentGC-FIDNo resolvable identifier
P-tolualdehydeAerial part of plantsSolvent extraction0.05 PercentGC-FIDNo resolvable identifier
Pentyl salicylateAerial part of plantsSolvent extraction0.07 PercentGC-FIDNo resolvable identifier
ScopoletinSeedSolvent extractionNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NeurotoxicityNeurologicAerial part of plantsSolvent extractionHuman (as organism)Case reportResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Jauregui, X., Clavo, Z.M., Jovel, E.M., Pardo-De-Santayana, M. Plantas con madre: Plants that teach and guide in the shamanic initiation process in the East-Central Peruvian Amazon. Journal of Ethnopharmacology, 2011, vol. 134, no. 3, p. 739-752. DOI
  2. Sanz-Biset, Jaume., Canigueral, Salvador. Plant use in the medicinal practices known as strict diets in Chazuta valley (Peruvian Amazon). JOURNAL OF ETHNOPHARMACOLOGY, 2011, vol. 137, no. 1, p. 271-288. DOI
  3. LLOYD, HA., FALES, HM., GOLDMAN, ME., JERINA, DM., PLOWMAN, T., SCHULTES, RE. BRUNFELSAMIDINE - A NOVEL CONVULSANT FROM THE MEDICINAL PLANT BRUNFELSIA-GRANDIFLORA. TETRAHEDRON LETTERS, 1985, vol. 26, no. 22, p. 2623-2624. DOI
  4. Castioni, P., Kapetanidis, I. Volatile constituents from Brunfelsia grandiflora ssp. grandiflora: Qualitative analysis by GC-MS. Scientia Pharmaceutica, 1996, vol. 64, no. 1, p. 83-91.
  5. de Campos, Sonia Machado. Scopoletin in Brunfelsia seeds. Anais. Acad. Brasil Cienc., 1964, p. 511-513.
  6. Fuchino, Hiroyuki., Sekita, Setsuko., Mori, Kanami., Kawahara, Nobuo., Satake, Motoyoshi., Kiuchi, Fumiyuki. A new leishmanicidal saponin from Brunfelsia grandiflora. CHEMICAL & PHARMACEUTICAL BULLETIN, 2008, vol. 56, no. 1, p. 93-96. DOI
  7. BENNETT, BC. HALLUCINOGENIC PLANTS OF THE SHUAR AND RELATED INDIGENOUS GROUPS IN AMAZONIAN ECUADOR AND PERU. BRITTONIA, 1992, vol. 44, no. 4, p. 483-493. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue